Advaxis, Inc. (ADXS)

USD 0.03

(0.0%)

Revenue Summary of Advaxis, Inc.

  • Advaxis, Inc.'s latest annual revenue in 2023 was 13 Thousand USD , down -94.8% from previous year.
  • Advaxis, Inc.'s latest quarterly revenue in 2023 FY was 13 Thousand USD , down -94.8% from previous quarter.
  • Advaxis, Inc. reported a annual revenue of 250 Thousand USD in annual revenue 2022, down -92.28% from previous year.
  • Advaxis, Inc. reported a annual revenue of 3.24 Million USD in annual revenue 2021, up 1180.63% from previous year.
  • Advaxis, Inc. reported a quarterly revenue of - USD for 2023 Q4, down 0.0% from previous quarter.
  • Advaxis, Inc. reported a quarterly revenue of 13 Thousand USD for 2023 FY, down -94.8% from previous quarter.

Annual Revenue Chart of Advaxis, Inc. (2023 - 2002)

Created with Highcharts 11.1.0YearsRevenue200220042006200820102012201420162018202020220 USD2500000 USD5000000 USD7500000 USD10000000 USD12500000 USD15000000 USD

Historical Annual Revenue of Advaxis, Inc. (2023 - 2002)

Year Revenue Revenue Growth
2023 13 Thousand USD -94.8%
2022 250 Thousand USD -92.28%
2021 3.24 Million USD 1180.63%
2020 253 Thousand USD -89.16%
2019 2.33 Million USD -61.5%
2018 6.06 Million USD -49.61%
2017 12.03 Million USD 201.16%
2016 3.99 Million USD 0.0%
2015 - USD -100.0%
2014 1 Million USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD -100.0%
2010 508.48 Thousand USD 1612.63%
2009 29.69 Thousand USD -54.83%
2008 65.73 Thousand USD -57.37%
2007 154.2 Thousand USD -64.3%
2006 431.96 Thousand USD -21.87%
2005 552.86 Thousand USD 374.95%
2004 116.4 Thousand USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%

Peer Revenue Comparison of Advaxis, Inc.

Name Revenue Revenue Difference
Evofem Biosciences, Inc. 18.21 Million USD 99.929%
Neon Bloom, Inc. - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Qrons Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.989%
Adynxx, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 99.327%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 98.026%
Arch Therapeutics, Inc. 75.72 Thousand USD 82.832%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.918%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD 26.224%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 99.939%
Intellipharmaceutics International Inc. 65.72 Thousand USD 80.222%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 99.78%
Marizyme, Inc. 645.81 Thousand USD 97.987%
Genus plc 668.8 Million USD 99.998%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.995%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 86.868%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 96.831%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD 83.064%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD 67.104%
MultiCell Technologies, Inc. 49.32 USD -26258.475%
ONE Bio Corp. 52.29 Million USD 99.975%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.974%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD 73.415%
Q BioMed Inc. 284.35 Thousand USD 95.428%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.956%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.991%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 97.669%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD 81.429%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 100.0%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -1201.301%
Enzolytics Inc. 52.79 Thousand USD 75.377%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 97.864%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.999%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 90.73%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 97.894%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.998%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 98.697%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.973%
BioStem Technologies, Inc. 16.68 Million USD 99.922%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 94.505%
Regen BioPharma, Inc. 236.56 Thousand USD 94.505%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 99.05%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 97.256%
SYBLEU INC 11.69 Thousand USD -11.149%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 99.833%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD 67.117%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 99.61%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 99.805%
IntelGenx Technologies Corp. 1.03 Million USD 98.749%
Gelesis Holdings, Inc. 25.76 Million USD 99.95%
CSL Limited 14.8 Billion USD 100.0%
Cellectis S.A. 755 Thousand USD 98.278%